Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-13-000030
Filing Date
2013-01-31
Accepted
2013-01-31 19:48:40
Documents
1
Period of Report
2013-01-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3983
  Complete submission text file 0001250853-13-000030.txt   5634
Mailing Address C/O OXIGENE, INC. 230 THIRD AVENUE WALTHAM MA 02451
Business Address
Chin Richard (Reporting) CIK: 0001337252 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 13564346

Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations